Results
1 -
10 of
35
(Click
here to explore results)
- Venoms to Drugs: Venom as a Source for the Development of Human Therapeutics, CHAPTER 5 Reptile Venoms as a Platform for Drug Development. Ryan J. R. McCleary, Tse S. Kang, R. Manjunatha Kini
, 2015
, Pages 129-162
- Amino Acids, Peptides and Proteins: Volume 38, Peptide and protein based pharmaceuticals. Gábor Mezo
, 2014
, Volume 38
, Pages 203-252
- Anti-fibrotic Drug Discovery, CHAPTER 1 TGFβ Signaling. Anne-Ulrike Trendelenburg
, 2020
, Pages 1-36
- Chemical Health Threats: Assessing and Alerting, CHAPTER 14 Investigating Outbreaks of Unknown Aetiology. S. Collins, T. Gaulton, T. James
, 2019
, Pages 240-262
- Amino Acids, Peptides and Proteins: Volume 31, Metal complexes of amino acids and peptides. J. S. Davies, E. Farkas, I. Solvago
, 2000
, Volume 31
, Pages 336-412
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 4 Natural Compounds and Synthetic Drugs to Target Type-2 Cannabinoid (CB2) Receptor. Wolfgang Guba, Marc Nazaré, Uwe Grether
, 2021
, Pages 89-167
- UHPLC in Life Sciences, Subject Index
, 2012
, Pages 429-447
- All-carbon Composites and Hybrids, Chapter 7 Carbon Dots Derived from Natural Carbon Sources: Preparation, Chemical Functionalization, Characterization, and Applications. Monikankana Saikia, Binoy K. Saikia
, 2021
, Pages 142-172
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- UHPLC in Life Sciences, Chapter 12 UHPLC-MS for Multi-residue Screening of Pharmaceuticals in Environmental Samples. Rebeca López-serna, Sandra Perez, Mira Petrovic*, Damià Barceló
, 2012
, Pages 337-353